Three global small-cap stocks with big potential
A professional investor tells us where he’d put his money. This week: Erik Esselink, European equities fund manager, Invesco, highlights three favourites

Global small-cap stocks often fail to gain the attention they perhaps deserve. Their appeal is frequently either underappreciated or overlooked, especially when the dominant narrative and newsflow routinely revolves around the attractions of Big Tech behemoths with trillion-dollar market valuations. Yet small-cap performance has been strong – and not just since the Covid-19 crisis.
Smaller companies have considerably outperformed larger companies since the turn of the century. This has been driven primarily by faster revenue and earnings growth, and we expect this to continue. While it is true that small-cap stocks can be more volatile than large caps, historically investors are rewarded with higher returns.
An encouraging worldwide backdrop
We see several good years of global economic growth ahead, and we believe this will make for an attractive environment for small-cap investing. We also expect mergers and acquisitions to be another important driver for small caps. Sometimes we buy from private equity and larger companies; more often we sell our businesses to them, normally at a significant premium.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Our focus is on identifying companies with durable, sustainable business models, where we have a differentiated view and see scope for a bargain to produce strong returns. While we continue to see attractively valued companies in most parts of the world, we would caution that valuations are somewhat stretched in those stocks and sectors popular with the consensus over the last 12 months. We think the stocks below, held within the Invesco Global Smaller Companies Fund (UK), are attractively valued.
A chemicals group with the right formula
Denka (Tokyo: 4061) is a chemicals company with significant global shares in highly profitable niche areas. Spherical alumina is a good example of a high-margin product with strong growth potential as it is used for electrical insulation and heat dissipation in electric-vehicle batteries. Products for the semiconductor and healthcare industries add to the company’s long term growth outlook.
The outlook at Samsonite (Hong Kong: 1910), the well-known global luggage brand, is also auspicious. The problem it has faced recently is that when no-one travels, no-one buys much luggage. However, the brand is super-strong and its scale leads to durable advantages in procurement, distribution, and research and development. As a result, it remains the global leader and sales should bounce back with the recovery from Covid-19. It has also used the sudden-stop experience of the pandemic to reduce costs, so we think it will emerge more profitable than ever when we get back to normal.
A bright future in LED lighting
Signify (Amsterdam: LIGHT) is a global leader in LED lighting solutions. While LED lighting is a highly competitive area, Signify has remained a leader in more complex “connected LED” solutions, whereby lighting is combined with IT systems. These offer companies even greater energy savings and better margins. There is ample scope for growth in this sector as we aim for a zero-carbon future and benefit from infrastructure stimulus packages around the world. Furthermore, Signify’s recent acquisition of Cooper in the US allows them to improve margins significantly in its corporate division.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Erik Esselink is European equities fund manager at Invesco
-
Hargreaves Lansdown slashes fees for ISA and SIPP investors - how does it compare to other providers?
Hargreaves Lansdown, the UK’s biggest investment platform, has dropped its fees by 40%, to their lowest ever level, for certain customers. Is it a good deal, and how does it compare to other providers?
By Ruth Emery
-
BP's 'long, painful decline' – and why next year could be even tougher
Opinion Long-suffering shareholders in oil giant BP have been pushing for change. It won’t come soon enough, says Matthew Lynn
By Matthew Lynn
-
BP's 'long, painful decline' – and why next year could be even tougher
Opinion Long-suffering shareholders in oil giant BP have been pushing for change. It won’t come soon enough, says Matthew Lynn
By Matthew Lynn
-
Investment trusts tap the profits in exotic and obscure global markets
Opinion Peter Walls, manager of the Unicorn Mastertrust fund, highlights three investment trusts as he shares where he'd put his money
By Peter Walls
-
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
By Dr Matthew Partridge
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?
Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
By Dr Matthew Partridge
-
Best of British bargains: cash in on undervalued companies in the UK stock market
Opinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
By Michael Field
-
Building firm Keller presents low debt and ample scope for growth
Geotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
By Dr Mike Tubbs
-
PZ Cussons share price down 75% in last decade – why it's one to watch
Opinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
By Jamie Ward
-
Cash in on the biotech sector with specialist trust BioPharma
Opinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
By Rupert Hargreaves